Use of nitrogen-containing compounds as antiparasitics, and compositions containing them
申请人:DRUG & VACCINE DEVELOPMENT CORPORATION
公开号:EP0355279A2
公开(公告)日:1990-02-28
The present invention relates to the treatment of diseases caused by invading organisms in a host by first identifying an enzymatic difference between the host and the invading organism and then administering to the host a pharmaceutically effective amount of a subversive substrate for the differing enzyme of the invading organism, whereby the action of the differing enzyme causes a result counter to the intended result and function of the enzyme that results in its debilitation or death. In particular, treatment of parasitic diseases caused by kinetoplastids including trypanosomes and leishmanias, e.g., African sleeping sickness, Chagas' disease, oriental sore and kala-azar is accomplished by administration of a pharmaceutically effective antiparasitic amount of a competitive toxigenic substrate for trypanothione reductase. Methods of treatment and compositions therefor lcontain a competitive toxigenic substrate for trypanothione reductase. Numerous compounds and corresponding compositions are disclosed.
本发明涉及对宿主体内入侵生物引起的疾病的治疗,方法是首先确定宿主与入侵生物之间的酶差异,然后向宿主施用药学上有效量的入侵生物差异酶的颠覆性底物,由此差异酶的作用引起与酶的预期结果和功能相反的结果,导致其衰弱或死亡。特别是,对由包括锥虫和利什曼病在内的动植体引起的寄生虫病,如非洲昏睡病、恰加斯病、东方疮和卡拉-扎尔病的治疗,是通过施用药理上有效的抗寄生虫量的锥硫还原酶竞争性毒性底物来实现的。治疗方法及其组合物含有胰硫蛋白还原酶的竞争性毒性底物。公开了许多化合物和相应的组合物。